 
	
  POUT-T
    
    http://www.icr.ac.uk/our-research/our-research-centres/clinical-trials-and-statistics-unit/clinical-trials/pout
  
 
 
  
POUT-T: The translational substudy of a phase III randomised trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer. The objectives of POUT-T are: to investigate the molecular pathogenesis of Upper Tract Urothelial Carcinoma (UTUC); to identify prognostic and predictive biomarkers of UTUC; and to identify diagnostic biomarkers of UTUC. POUT-T participants are requested to provide the following specimens pre-operatively, post operatively, 6 months following surgery, and at disease recurrence: whole blood for germline DNA analysis; whole blood for cell-free DNA analysis; first moning urine for DNA, proteome and metabolome analyses. In addition, paraffin-embedded tumour tissue from nephro-ureterectomy is requested for immunohistochemistry and DNA/RNA analyses.
Existing samples:
- Malignant tumor of urinary bladder (disorder)
- Transitional cell carcinoma (morphologic abnormality)
Contact Information
- Email:
- R.T.Bryan@bham.ac.uk
- Address:
- 
      
 Mr Rik Bryan
 POUT-T
 The Institute of Cancer & Genomic Sciences
 University of Birmingham
 Birmingham
 Warwickshire
 B15 2TT
 England
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A | 
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A | 
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A | 
| 2018 | N/A | N/A | N/A | N/A | N/A | N/A | 
| 2019 | N/A | N/A | N/A | N/A | N/A | N/A | 
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A | 
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A | 
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A | 
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A | 
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A | 
| 2025 | N/A | N/A | N/A | N/A | N/A | N/A |